Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria

427. Skander, D., Allenova, A., Maurer, M., and Kolkhir, P.+: Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. Eur. Ann. Allergy Clin. Immunol. 2021: 53; 91-93. IF: N/A

o.427